Managing bridging data for regulatory purposes
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: RSC-006
- By: HWANG, Yu Ya (Taipei Medical University, Taiwan China)
- Co-author(s): Ms Yu Ya Hwang (Taipei Medical University, Taipei City, Taiwan China)
Due to the complexity of biosimilar drugs, regulations concerning biosimilars were considered highly difficult to be addressed. Thus, the evaluation procedure requires a more profound structure. By managing bridging data more efficiently, we may lower down technical barriers to cross-regional trade may be and drug quality, .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019